<DOC>
	<DOCNO>NCT00308308</DOCNO>
	<brief_summary>To determine safety efficacy inhaled insulin treatment type 1 diabetes</brief_summary>
	<brief_title>Efficacy &amp; Safety Inhaled Insulin Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Clinical diagnosis type 1 diabetes least 1 year Nonsmokers prior 6 month BMI le equal 35kg/m2 HbA1c &gt; = 7 % &lt; = 11 % Serum creatinine &lt; = 1.8 mg/dL female subject &lt; = 2.0 mg/dL male subject FEV1 &gt; = 70 % predict , DLco &gt; = 70 % , TLC &gt; = 80 % predicted Maintenance treatment regimen insulin less equal 1.4 iu/kg/day Urine cotinine &lt; = 100 ng/mL History chronic obstructive pulmonary disease , asthma , clinically significant pulmonary disease confirm documented history , pulmonary function test radiologic finding Evidence severe complication diabetes Aminotransferase and/or alanine aminotransferase &gt; 3 time upper limit normal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>